President Donald Trump is again trying to exert control over American elections, signing an executive order Tuesday that aims to create federal lists of citizens and ask the U.S. Postal Service to ...

In moments of loneliness or boredom, an imaginary friend can be the perfect companion to alleviate those feelings. Whether you’re a child looking for a playmate or an adult seeking some companionship, ...

The NCAA Tournament field for the men and women are set and millions of people are finalizing their 2026 March Madness brackets and agonizing over their picks. The first round of the men's tournament ...

CU Boulder researchers have discovered an appetite-suppressing compound in python blood that helps the snakes consume enormous meals and go months without eating yet remain metabolically healthy. The ...

If you’ve ever wondered how to make an AI picture but felt intimidated by “prompt engineering” or complicated design tools, you’re not alone. Many people are curious about AI art or photo editing but ...

A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...

The 18 long-living perennials that will last for decades include varieties like hostas, daylilies, echinacea, sedum, and lavender, each selected for resilience, low maintenance, and repeated blooms, ...

Walk into some homes and you feel it immediately: noise bouncing off hard surfaces, lights that seem too bright, clutter that keeps pulling your eye in a dozen directions. For many people, that is ...

To build an AI agent, beginners should use OpenAI Agent Builder. It's a visual tool that lets you easily create multi-agent systems. You can test, iterate, and develop AI agents and publish them as ...

At a time when New York is facing fiscal headwinds and difficult choices, it’s easy to believe that cutting funding is the only way forward. But what if the answer isn’t necessarily about spending ...

Cell therapy company Link Cell Therapies is launching with $60 million and a mission to develop potent CAR-T therapies that go after a range of tumors while avoiding patients' healthy tissue. The ...